Guideline-directed statin intensification in patients with new or worsening symptoms of peripheral artery disease

Background The ACC/AHA cholesterol guidelines recommend patients with peripheral artery disease (PAD) be treated with a moderate to high‐intensity statin. The extent to which patients with new or worsening PAD symptoms are offered guideline therapy is unknown.